Skip to main content
Download PDF
  • Editorial Expression of Concern
  • Open access
  • Published:

Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801

BMC Cancer volume 22, Article number: 665 (2022) Cite this article

The Original Article was published on 10 October 2013

BMC Cancer 13, 468 (2013)

https://doi.org/10.1186/1471-2407-13-468

The Editor is issuing an editorial expression of concern to alert readers that concerns have been raised about possible figure duplication in Figure 1B. Panels HepG2 and HuH-7 appear to be nearly identical. The authors no longer have access to raw data and therefore cannot provide a replacement image. The Editor advises readers to interpret the results of this section of the article with caution [1].

Authors Fuminori Yamaguchi and Kazuyo Kamitori agree to this Editorial Expression of Concern. Authors Hossain Akram and Masaaki Tokuda have not responded to any correspondence from the editor or publisher about this Editorial Expression of Concern. The editor was not able to obtain a current email address for authors Yuko Hirata, Youyi Dong and Li Sui.

Reference

  1. Yamaguchi F, Hirata Y, Akram H, et al. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer. 2013;13:468. https://doi.org/10.1186/1471-2407-13-468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Cell Physiology, Faculty of Medicine, Kagawa University, 1750-1, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan

    Fuminori Yamaguchi, Yuko Hirata, Hossain Akram, Kazuyo Kamitori, Youyi Dong, Li Sui & Masaaki Tokuda

Authors
  1. Fuminori Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuko Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hossain Akram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuyo Kamitori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Youyi Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Sui
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masaaki Tokuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fuminori Yamaguchi.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamaguchi, F., Hirata, Y., Akram, H. et al. Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer 22, 665 (2022). https://doi.org/10.1186/s12885-022-09764-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-09764-1

BMC Cancer

ISSN: 1471-2407

Contact us